"Fallopian Tube Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
Descriptor ID |
D005185
|
MeSH Number(s) |
C04.588.945.418.365 C13.351.500.056.390.390 C13.351.937.418.365
|
Concept/Terms |
Fallopian Tube Neoplasms- Fallopian Tube Neoplasms
- Fallopian Tube Neoplasm
- Neoplasm, Fallopian Tube
- Neoplasms, Fallopian Tube
Fallopian Tube Cancer- Fallopian Tube Cancer
- Cancer, Fallopian Tube
- Cancers, Fallopian Tube
- Fallopian Tube Cancers
- Cancer of the Fallopian Tube
|
Below are MeSH descriptors whose meaning is more general than "Fallopian Tube Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Fallopian Tube Neoplasms".
This graph shows the total number of publications written about "Fallopian Tube Neoplasms" by people in this website by year, and whether "Fallopian Tube Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fallopian Tube Neoplasms" by people in Profiles.
-
Ersoy E, Kashikar RM. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases. J Am Soc Cytopathol. 2020 Jul - Aug; 9(4):266-271.
-
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 08 20; 322(7):652-665.